Articles
Covid-19 pandemic: information and resources to support the cancer care community
As soon as the first analysis of the risk for severe COVID-19 in patients with cancer was published online in Lancet Oncology on February 14th, 2020, it emerged that these…
Delivering the best cancer care during the pandemic
Key messages from the e-ESO faculty On March 18, the European School of Oncology presented an interactive webinar on how to do this, drawing on the limited data available, the…
The ABC Global Alliance launch a Global campaign to raise awareness about advanced breast cancer
There are over two million new cases of breast cancer a year in the world and 0.6 million deaths. About a third of all early breast cancer cases will become…
Women make great surgeons, so why is the profession still dominated by men?
Professor Isabel Rubio is a surgeon at the top of her profession. She is Director of Breast Surgery at Clinica Universidad de Navarra, Madrid. She is President-elect of the European…
Evidence-based medicine and precision medicine – irreconcilable or inseparable?
“Medicine cannot be learned quickly, because it is impossible for there to exist any established method in it, as for example when someone who has learned to write in one…
How retractions are helping cancer research
In 2015, cancer researcher Anil Potti – back then associated with Duke University in Durham, North Carolina – was found guilty of research misconduct by a US federal investigation led…
Right drug, wrong patient: here’s how we improve our targeting
When it comes to precision and personalised medicine (PPM), clinical practice in oncology takes pride in developing and administering treatments that selectively target components of tumour cells. But, PPM is…
How to make precision drugs that work better
Six lessons from the development of the first targeted anti-cancer therapy Tamoxifen famously started life as a failed contraceptive, developed by ICI (now Astra Zeneca), but with the fatal flaw…
AI will help Cinderella to see herself in the mirror
Many women who undergo breast reconstruction after mastectomy end up disappointed. It is estimated that as many as 30% of women have to live with aesthetic results they are not…
The unique toxicities of CAR-T cell therapy
The advent of chimeric antigen receptor T cell (CAR T cell) therapy generated great excitement in the field of onco-haematology. Clinical trials have shown remarkable results in patients with…